Cantex Pharmaceuticals develops novel treatments for inflammatory lung diseases and cancer.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/24/2014 | Series D | $34.31MM | $xx.xx | $276.31MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
35,599,966
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
04/23/2014 | Series C | $9.41MM | $xx.xx | $18.44MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
115,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|
||||||
09/05/2006 | Series B | $20.52MM | $xx.xx | $41.99MM | Aurora Funds, Chl Medical Partners, Domain Associates, Research Corp. Technologies | |
Price per Share
$xx.xx
Shares Outstanding
12,993,113
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Aurora Funds, Chl Medical Partners, Domain Associates, Research Corp. Technologies
|
||||||
08/12/2002 | Series A-1 | $1.6MM | $xx.xx | $7.35MM | Academy Venture Fund, A.P. Kennedy Family Securities, Research Corporation Technologies | |
Price per Share
$xx.xx
Shares Outstanding
1,600,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Academy Venture Fund, A.P. Kennedy Family Securities, Research Corporation Technologies
|
||||||
08/12/2002 | Series A-2 | $2.02MM | $xx.xx | $7.35MM | Academy Venture Fund, A.P. Kennedy Family Securities, Research Corporation Technologies | |
Price per Share
$xx.xx
Shares Outstanding
1,359,060
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Academy Venture Fund, A.P. Kennedy Family Securities, Research Corporation Technologies
|